Cardiology
CJC-1295
Studies on CJC-1295, a long-acting GHRH analog, in growth hormone axis and body-composition research contexts.
Unknown pathwayAlso known as: CJC-1295, CJC1295, growth hormone releasing hormone analog
0
Claims analyzed
What does the research say about CJC-1295?
Unknown pathwayBased on 0 claims ( agreements, contradictions)
Topic has no MeSH concept mappings
Stay current on CJC-1295
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Evidence brief: CJC-1295
CJC-1295 (also known as CJC-1295, CJC1295, growth hormone releasing hormone analog). Studies on CJC-1295, a long-acting GHRH analog, in growth hormone axis and body-composition research contexts.
As of 2026-08-14, the scientific consensus on CJC-1295 is unknown. Topic has no MeSH concept mappings
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-cjc-1295.
Deterministic synthesis from Synapse's enriched corpus — 53 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Follow the latest CJC-1295 research
Explore every CJC-1295 paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.